PTK2 and non-small cell lung carcinoma: We investigated the effects of two FAK inhibitors, PF-573,228 (PF-228) and PF-562,271 (PF-271) on NSCLC cell growth in culture and tumor growth in mouse xenograft models as both single agents and in combination with erlotinib.